Elicio Therapeutics, Inc.
ELTX
$2.18
-$0.17-7.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 30.50% | -53.19% | 23.46% | 4.53% | 5.78% |
| Total Depreciation and Amortization | -2.08% | 1.05% | 1.06% | 0.71% | 1.08% |
| Total Amortization of Deferred Charges | -11.76% | -68.66% | 720.00% | -- | -100.00% |
| Total Other Non-Cash Items | -183.59% | 281.39% | -117.54% | 246.28% | 48.63% |
| Change in Net Operating Assets | 161.89% | -241.14% | 134.43% | -1,090.60% | 0.85% |
| Cash from Operations | 29.88% | -71.33% | 38.69% | -23.87% | 11.55% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 114.50% | 66.32% | -49.20% | 222.72% | -71.28% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,275.41% | -- | -- | -- | -- |
| Cash from Financing | 105.68% | 65.06% | -49.20% | -19.78% | 15.53% |
| Foreign Exchange rate Adjustments | -180.00% | 105.21% | -346.15% | -47.30% | 138.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 330.86% | -76.59% | -38.71% | -148.27% | 1,173.33% |